165 related articles for article (PubMed ID: 6406781)
21. Tumor growth-stimulating and inhibiting effects of antiestrogens on the DMBA-induced mammary carcinoma of the ovariectomized, diethylstilbestrol-treated SD rat. A study on the mechanism of action of antiestrogens.
Hartmann RW
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):959-64. PubMed ID: 6309529
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory actions of keoxifene on luteinizing hormone secretion in pituitary gonadotrophs.
Ortmann O; Emons G; Knuppen R; Catt KJ
Endocrinology; 1988 Aug; 123(2):962-8. PubMed ID: 3293992
[TBL] [Abstract][Full Text] [Related]
23. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Waseda N; Kato Y; Matsushita N; Imura H
Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151
[TBL] [Abstract][Full Text] [Related]
24. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
Wakeling AE; Valcaccia B
J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
[TBL] [Abstract][Full Text] [Related]
25. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
Fendl KC; Zimniski SJ
Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
[TBL] [Abstract][Full Text] [Related]
26. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
[TBL] [Abstract][Full Text] [Related]
27. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
[TBL] [Abstract][Full Text] [Related]
28. Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata.
Jordan VC
Eur J Cancer (1965); 1976 Jun; 12(6):419-24. PubMed ID: 821733
[No Abstract] [Full Text] [Related]
29. Long-term dysregulation of circadian and 17-beta estradiol-induced LH, prolactin and corticosterone secretion after dimethylbenz (a) anthracene administration in the Sprague-Dawley female rat.
Yon de Jonage-Canonico MB; Lenoir V; Scholler R; Kerdelhué B
Breast Cancer Res Treat; 2005 Jul; 92(1):47-50. PubMed ID: 15980990
[TBL] [Abstract][Full Text] [Related]
30. In vitro LHRH release: correlation with the LH surge and alteration by a mammary carcinogen.
Kerdelhue B; Peck EJ
Peptides; 1981; 2(2):219-22. PubMed ID: 6794013
[TBL] [Abstract][Full Text] [Related]
31. [Influence of calcitonin and ACTH 4-10 on the phenomena of mammary tumor induction by a chemical carcinogen, 7,12-dimethylbenzanthracene].
Drouhault R; Dufy B
C R Seances Soc Biol Fil; 1984; 178(3):278-85. PubMed ID: 6093951
[TBL] [Abstract][Full Text] [Related]
32. Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model.
Neubauer BL; Best KL; Counts DF; Goode RL; Hoover DM; Jones CD; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
Prostate; 1995 Oct; 27(4):220-9. PubMed ID: 7479389
[TBL] [Abstract][Full Text] [Related]
33. Antiestrogen modulation of the growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats.
Tsai TL; Rutledge S; Katzenellenbogen BS
Cancer Res; 1979 Dec; 39(12):5043-50. PubMed ID: 227594
[No Abstract] [Full Text] [Related]
34. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
35. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
36. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E
Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630
[TBL] [Abstract][Full Text] [Related]
37. Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen.
Hollingsworth AB; Lerner MR; Lightfoot SA; Wilkerson KB; Hanas JS; McCay PB; Brackett DJ
Breast Cancer Res Treat; 1998 Jan; 47(1):63-70. PubMed ID: 9493977
[TBL] [Abstract][Full Text] [Related]
38. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
Zaccheo T; Giudici D; Lombardi P; di Salle E
Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
[TBL] [Abstract][Full Text] [Related]
39. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
Jordan VC
J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
[TBL] [Abstract][Full Text] [Related]
40. Induction of pituitary and mammary tumors in male, "fale" and female rats by either DMBA, estradiol implant or combined treatment.
Kao KJ; Ramirez VD
Proc Soc Exp Biol Med; 1979 Mar; 160(3):296-301. PubMed ID: 107519
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
